| # | Drug | Count |
|---|---|---|
| 0 | DIAZEPAM | 7 |
| 1 | DIAZEPAM ORAL | 7 |
| 2 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 7 |
| 3 | INFLIXIMAB-DYYB | 6 |
| 4 | INFLIXIMAB | 5 |
| 5 | LORATADINE | 5 |
| 6 | LORATADINE ORAL | 5 |
| 7 | MYCOPHENOLATE MOFETIL | 3 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 3 |
| 9 | BELIMUMAB | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 6 | 0.0017 |
| 1 | DORAVIRINE | 1 | 0.0013 |
| 2 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 1 | 0.0005 |
| 3 | RALTEGRAVIR | 1 | 0.0002 |
| 4 | ICATIBANT ACETATE | 1 | 0.0002 |
| 5 | TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM | 1 | 0.0001 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 7 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 1 | 0.0001 |
| 8 | MINOCYCLINE | 1 | 0.0001 |
| 9 | GOLIMUMAB | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 1 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 2 | 0.0001 |
| 2 | Bile Acid [EPC] | 1 | 0.0000 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Antirheumatic Agent [EPC] | 2 | 0.0000 |
| 6 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |
| 7 | Cardiac Glycoside [EPC] | 1 | 0.0000 |
| 8 | Arteriolar Vasodilator [EPC] | 1 | 0.0000 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 12 | 0.0000 |